Why Ultralife Corporation’s (ULBI) Stock Is Up 5.69%
As of Tuesday, July 21, Ultralife Corporation’s ULBI share price has surged by 5.69%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Jenna Brashear
Tudor Pop
Michael Rose
Michael Rose
| Share Statistics | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $86.4 | $832.7 | 21% |
|
| Shares Out (Mil) | 16.7 | 51.7 | 28% |
|
| Institutional Ownership | 43.6% | 72.9% | 19% |
|
| Float (Mil) | 9.6 | 52.6 | 19% |
|
| Beta | 0.74 | 1.18 | 43% |
|
| Avg Daily Volume (000s) | 29 | 444 | 24% |
|
| Price Change (52-week) |
(36.8%) | 46.2% | 21% |
|
| Growth | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 12.2% | 9.3% | 66% |
|
| Net Income (5yr) | (25.7%) | (1.7%) | 16% |
|
| EPS (5yr) | (25.2%) | 10.4% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (5.6%) | (14.6%) | 61% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $188 | $501 | 32% |
|
| Net Income (TTM) (Mil) | ($8) | ($2) | 31% |
|
| EPS (TTM) | ($0.493) | ($0.200) | 28% |
|
| Operating Cash Flow (TTM) (Mil) | $10 | ($1) | 38% |
|
| Net Cash Flow (TTM) (Mil) | $0 | $3 | 44% |
|
| Long-Term Debt (Q1) (Mil) | $46 | $45 | 38% |
|
| Enterprise Value (Q1) (Mil) | $163 | $1,170 | 25% |
|
| Valuation | ULBI | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.67 | 2.50 | 13% |
|
| P/E | na | 38.2 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | ULBI | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 23.1% | 28.1% | 25% |
|
| Net Margin | (4.4%) | 1.0% | 26% |
|
| ROA | (3.7%) | (4.3%) | 32% |
|
| ROE | (6.2%) | 7.9% | 30% |
|
| Liabilities to Assets | 41.2% | 57.5% | 32% |
|
| F-Score | 3 | 4 | 19% |
|
Ultralife Corporation did not pass any screens on 7/31/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors